Margin resik Onconetix Corporation (ONCO)

Logo perusahaan publik Onconetix Corp (ONCO)

Effective sales margins demonstrate profit sensitivity to external factors, with the current value standing at -7423.90. Onconetix, Inc. (ONCO) is mitigating patent risks by developing antiviral agents and medications for men. A team of oncology experts is focusing on the precision of new diagnostic methods. Current revenue is based on the sale of therapeutic products while awaiting approval for new regulatory expansions.

onconetix.gcs-web.com (ONCO) - Margin resik saka 21.02.2024 nganti 20.11.2026

Ringkesan rincian data analitis Onconetix, Inc. (ONCO)

- nilai pasar lan prakiraan target analis:
- rincian kapitalisasi pasar:
Ringkesan analisis perusahaan:Onconetix, ONCO
Barang unggulan Onconetix Corporation

Sales margin is calculated as the ratio of net income to revenue, reflecting the efficiency of overall cost management. This indicator allows investors to distinguish fundamental growth from short-term market volatility, eliminating the risk of purchasing an overvalued asset. For Onconetix, Inc. (ONCO), this metric confirms financial stability amid the diversification of its antiviral and specialized drug portfolio. The development of the clinical pipeline directly impacts future profitability. By analyzing the revenue profitability level, an investor assesses the company's ability to convert innovation into a stable cash flow.

Karo sapa Onconetix, Inc. saingan

A (Agilent Technologies) - Rentabilitas dodolan miturut bathi resik|DGX: Rentabilitas resik perusahaan|Margin resik Illumina Platform|EXAS (Exact Sciences) - Rentabilitas resik perusahaan|Rentabilitas dodolan miturut bathi resik RVTY (PerkinElmer)|Bio-Rad - Rentabilitas dodolan resik|Margin dodolan resik NNNN (Anbio)|Tingkat bathi resik SHC|QDEL - Margin resik|OPK: Margin resik|caredx.com (CDNA) - Margin resik|MRVI (Maravai LifeSciences) - Margin resik|FLGT (Fulgent) - Margin dodolan resik|Standard BioTools Inc (LAB) - Margin dodolan perusahaan|Margin dodolan resik CTKB|Rentabilitas dodolan miturut bathi resik OraSure Technologies Inc OSUR|Margin dodolan resik XGN (Exagen Diagnostics)|Margin dodolan resik mdxhealth.com MDXH|LUCD - Margin resik|PRE: Margin resik|IMDX (Insight Molecular Diagnostics Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan miturut bathi resik Trinity Biotech PLC|PRPH (prophaselabs.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Ainos, Inc. (AIMD)|Margin dodolan resik CODX|HSCS (HeartSciences) - Tingkat bathi resik|Margin resik Biomerica, Inc BMRA|CDIO - Rentabilitas dodolan miturut bathi resik|VRAX: Rentabilitas dodolan miturut bathi resik|bluejaydx.com (BJDX) - Rentabilitas dodolan miturut bathi resik|AWH: Margin dodolan resik|AXDX: Rentabilitas resik perusahaan|CNTG (CENTOGENE N.V.) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Enzo Biochem, Inc. (ENZ)|FRES - Margin bathi resik|Genetic Technologies Limited (GENE) - Tingkat bathi miturut bathi resik|Margin dodolan resik ME (23andme.com)|Psychemedics Corp. (PMD) - Margin resik